What is CommonQuant (Common Quant)?

CommonQuant, also written Common Quant, is an AI-powered trading platform that turns plain-English market ideas into live, rules-based strategies. It selects relevant instruments, writes indicator-based entry and exit rules, monitors the conditions continuously, and alerts users when conditions are met.

How does CommonQuant generate trading strategies?

You write a natural-language prompt describing your market idea. CommonQuant selects validated instruments, chooses from 20 supported technical indicators, and writes concrete entry and exit rules. The strategy then runs live and sends alerts through the channels available on your plan when conditions trigger.

What markets and instruments does CommonQuant support?

CommonQuant supports several thousand US equities and ETFs listed on Nasdaq, NYSE, NYSE American, and Cboe, plus major crypto assets such as Bitcoin. It does not support FX or futures.

How do I receive trading signal alerts?

CommonQuant provides an in-app signal inbox on all plans. Paid plans add email and Telegram, plus metered monthly SMS and WhatsApp allowances. Channel availability and allowances vary by plan.

Is CommonQuant free to use?

Yes. CommonQuant has a free tier with 1,000 starter credits, 200 monthly refill credits, up to three signal subscriptions, and in-app alerts. Paid plans start at $9/month, and no credit card is required to start.

Does CommonQuant provide financial advice?

No. CommonQuant is a quantitative tool for alpha validation and does not constitute financial advice. Past performance does not guarantee future results. Users are responsible for their own trading decisions.

Can I copy public trading strategies?

Yes. Users can browse, preview, and copy public community and AI-generated strategies into their own accounts. They can also follow strategists and take part in Arena competitions.

CommonQuant.ai Research

AI-generated trading idea · SHORT · BAYRY

Bayer faces make-or-break court rulings after a $60 billion wipeout — bet against the pharma giant

Bayer's stock has been crushed over the last few years, losing $60 billion in value. The company's entire future now depends on the outcomes of two upcoming major court cases.

Idea

When a massive pharmaceutical and chemical company loses more than $60 billion in value, it tells you the market is terrified of the legal liabilities piling up. With two critical court decisions looming, this is a classic high-risk event. If either ruling goes against Bayer, the stock could plunge further as new damages or penalties are announced. This is a bet that the bad news isn't fully priced in yet and the fallout will continue.

Key details

BAYRY1D#pharma#legal#event-risk

Community

Upvotes

Views

Copies

Cosigns

News sources

Bayer Shares Hinge On Two Court Decisions After $60 Billion Rout — Bloomberg

BAYRY trade ideas
Latest market news

Bayer faces make-or-break court rulings after a $60 billion wipeout — bet against the pharma giant

Idea

Key details

Community

News sources

Related